Glaukos logo

Glaukos

4 followers

At Glaukos, their focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

Industries

Employees

501-1,000

Links


Org chart

Thomas W. Burns
President & CEO
Collapse
Joseph E. Gilliam
President & Chief Operating Officer
Jay L. Katz
Chief Medical Officer
Tomas Navratil
Chief Development Officer at Glaukos (R&D, Engineering, Clinical Development, Regulatory Affairs)
Diane W. Biagianti
Senior Vice President, Governance
Robert Davis
Senior Vice President And General Counsel
Jane E. Rady
SVP, Corporate Strategy & Business Development
Mike Neilon
Vice President
Gabriella Szekely
Sr. Vice President, R&D, Combination Pharmaceutical Products and Drug Delivery Innovation

Board & advisors

Mark J. Foley
Board Member
Denice M. Torres
Director Board Of Directors, member Compensation, Nom/Goc Committee
Leana S. Wen
Director